Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4401999
  • Report
  • 346 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 2X Oncology Inc
  • Becton Dickinson and Co
  • Fahy Gurteen UK Ltd
  • Laboratorios SALVAT SA
  • Olympia Diagnostics, Inc
  • Rosetta Genomics Ltd
  • MORE
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Ovarian Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ovarian Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ovarian Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 2X Oncology Inc
  • Becton Dickinson and Co
  • Fahy Gurteen UK Ltd
  • Laboratorios SALVAT SA
  • Olympia Diagnostics, Inc
  • Rosetta Genomics Ltd
  • MORE
1 Table of Contents
2 Introduction
2.1 Ovarian Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Ovarian Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Ovarian Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Ovarian Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Ovarian Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Ovarian Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Ovarian Cancer Diagnostic Tests Companies and Product Overview
5.1 2X Oncology Inc Company Overview
5.2 A&G Pharmaceutical Inc Company Overview
5.3 Abnova Corp Company Overview
5.4 Advanced Marker Discovery SL Company Overview
5.5 Almac Diagnostics Ltd Company Overview
5.6 ANGLE plc Company Overview
5.7 AroCell AB Company Overview
5.8 Aurelium BioPharma Inc. Company Overview
5.9 Avant Diagnostics, Inc. Company Overview
5.10 Axela Inc Company Overview
5.11 Ayanda Biosystems SA (Inactive) Company Overview
5.12 BARD1 Life Sciences Ltd Company Overview
5.13 Becton Dickinson and Co Company Overview
5.14 BioFluidica Microtechnologies LLC Company Overview
5.15 Bioindustry Park Silvano Fumero SpA Company Overview
5.16 Bioprognos SL Company Overview
5.17 Celcuity LLC Company Overview
5.18 Ceres Nanosciences Inc Company Overview
5.19 Chronix Biomedical Inc Company Overview
5.20 Clarient Inc Company Overview
5.21 ClavGen Therapeutics LLC Company Overview
5.22 Cleveland Diagnostics Inc. Company Overview
5.23 Courtagen Life Sciences Inc Company Overview
5.24 Dana-Farber Cancer Institute Inc Company Overview
5.25 Diazyme Laboratories Inc Company Overview
5.26 Eventus Diagnostics Inc (Inactive) Company Overview
5.27 Exiqon A/S Company Overview
5.28 Exosomics Siena SpA Company Overview
5.29 Fahy Gurteen UK Ltd Company Overview
5.30 French National Institute of Health and Medical Research Company Overview
5.31 Fujirebio Diagnostics Inc Company Overview
5.32 Ganymed Pharmaceuticals AG Company Overview
5.33 GeneNews Ltd Company Overview
5.34 Georgia Institute of Technology Company Overview
5.35 GlycoZym Company Overview
5.36 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
5.37 Hide and Seq Company Overview
5.38 Ikonisys Inc Company Overview
5.39 InterGenetics Inc Company Overview
5.40 IV Diagnostics Inc Company Overview
5.41 John Hopkins University Company Overview
5.42 King Abdullah University of Science and Technology Company Overview
5.43 KIYATEC Inc Company Overview
5.44 Lab Discoveries Ltd Company Overview
5.45 Laboratorios SALVAT SA Company Overview
5.46 Laboratory Corp of America Holdings Company Overview
5.47 Lantern Pharma Inc Company Overview
5.48 Louisville Bioscience, Inc. Company Overview
5.49 MabCure Inc. Company Overview
5.50 Massachusetts Institute of Technology Company Overview
5.51 MDNA Life Sciences Inc Company Overview
5.52 MDxHealth SA Company Overview
5.53 Metabolon Inc Company Overview
5.54 Milagen Inc Company Overview
5.55 MyCartis NV Company Overview
5.56 Myriad Genetics Inc Company Overview
5.57 Nanocytomics LLC Company Overview
5.58 National University of Singapore Company Overview
5.59 NGeneBio Co Ltd Company Overview
5.60 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
5.61 Olympia Diagnostics, Inc Company Overview
5.62 Oncgnostics GmbH Company Overview
5.63 Oncimmune (USA) LLC Company Overview
5.64 Orion Genomics LLC Company Overview
5.65 Oryzon Genomics SA Company Overview
5.66 OTraces Inc. Company Overview
5.67 Peregrine Pharmaceuticals, Inc. Company Overview
5.68 PeriRx LLC Company Overview
5.69 Phenomenome Discoveries Inc Company Overview
5.70 Precision Biologics Inc Company Overview
5.71 Protagen AG Company Overview
5.72 Proteomika Company Overview
5.73 Provista Diagnostics Inc Company Overview
5.74 Roche Diagnostics International Ltd Company Overview
5.75 Rosetta Genomics Ltd Company Overview
5.76 SomaLogic Inc Company Overview
5.77 Soricimed Biopharma Inc Company Overview
5.78 Stage I Diagnostics Inc Company Overview
5.79 SurExam Life Science & Technology Co. Company Overview
5.80 Target Discovery Inc (Inactive) Company Overview
5.81 Teva Pharmaceutical Industries Ltd Company Overview
5.82 The University of Adelaide Company Overview
5.83 Treos Bio Inc Company Overview
5.84 University of Arkansas for Medical Sciences Company Overview
5.85 University of California San Diego Company Overview
5.86 University of Chicago Company Overview
5.87 University of Montreal Company Overview
5.88 University of Pittsburgh Company Overview
5.89 University of South Florida Company Overview
5.90 University of Texas MD Anderson Cancer Center Company Overview
5.91 US Biomarkers Inc Company Overview
5.92 Vermillion Inc Company Overview
5.93 Vitatex Inc. Company Overview
5.94 Vitruvian Biomedical Inc Company Overview
5.95 Yale University Company Overview
6 Ovarian Cancer Diagnostic Tests - Recent Developments
6.1 Sep 11, 2017: Teva Names Kare Schultz as President and Chief Executive Officer
6.2 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index
6.3 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
6.4 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses
6.5 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
6.6 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
6.7 Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs
6.8 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
6.9 Aug 24, 2017: AroCell: Interim report, Q2 2017
6.10 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer
6.11 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
6.12 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
6.13 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
6.14 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
6.15 Aug 03, 2017: Teva Reports Second Quarter 2017 Financial Results
6.16 Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results
6.17 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results
6.18 Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
6.19 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017
6.20 Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting
6.21 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance
6.22 Jul 23, 2017: Teva to Terminate Around 300 jobs in Israel
6.23 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results
6.24 Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
6.25 Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
6.26 Jul 13, 2017: Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
6.27 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China
6.28 Jul 04, 2017: ANGLE Reports Successful Headline Data in US and European Ovarian Cancer Studies in 400 Patients
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Ovarian Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Ovarian Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Ovarian Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Ovarian Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Ovarian Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: 2X Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: 2X-131 Companion Diagnostic Assay - Product Status
Table 10: 2X-131 Companion Diagnostic Assay - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Companion Diagnostic Test - Ovarian Cancer - Product Status
Table 13: Companion Diagnostic Test - Ovarian Cancer - Product Description
Table 14: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Biomarker Test - Ovarian Cancer - Product Status
Table 16: Biomarker Test - Ovarian Cancer - Product Description
Table 17: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Biomarker Diagnostic Test - Ovarian Cancer - Product Status
Table 19: Biomarker Diagnostic Test - Ovarian Cancer - Product Description
Table 20: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: ALM AADx Assay - Product Status
Table 22: ALM AADx Assay - Product Description
Table 23: Diagnostic Test - Ovarian Cancer - Product Status
Table 24: Diagnostic Test - Ovarian Cancer - Product Description
Table 25: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
Table 26: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
Table 27: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Parsortix-Based Test - Ovarian Cancer - Product Status
Table 29: Parsortix-Based Test - Ovarian Cancer - Product Description
Table 30: ANGLE plc - Ongoing Clinical Trials Overview
Table 31: Parsortix-Based Test - Ovarian Cancer - Evaluation of Multiple Circulating Tumor Cell-derived RNA Markers to Estimate Risk of Ovarian Cancer in Patients Presenting with a Pelvic Mass: ANG-001 Pelvic Mass Training Study
Table 32: Parsortix-Based Test - Ovarian Cancer - Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting with a Pelvic Mass: ANG-003 EMBER Study
Table 33: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
Table 34: TK 210 Assay - Ovarian Cancer - Product Status
Table 35: TK 210 Assay - Ovarian Cancer - Product Description
Table 36: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MMD ELISA Test - Ovarian Cancer - Product Status
Table 38: MMD ELISA Test - Ovarian Cancer - Product Description
Table 39: MMD QPCR Test - Ovarian cancer - Product Status
Table 40: MMD QPCR Test - Ovarian cancer - Product Description
Table 41: Ovarian Cancer Screening Test - Product Status
Table 42: Ovarian Cancer Screening Test - Product Description
Table 43: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 44: OvaDx - Product Status
Table 45: OvaDx - Product Description
Table 46: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Multiplex Ovarian Cancer Biomarker Assay - Product Status
Table 48: Multiplex Ovarian Cancer Biomarker Assay - Product Description
Table 49: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Diagnostic Test - Ovarian Cancer - Product Status
Table 51: Diagnostic Test - Ovarian Cancer - Product Description
Table 52: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 53: BARD1 Ovarian Cancer Test - Product Status
Table 54: BARD1 Ovarian Cancer Test - Product Description
Table 55: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Diagnostic Test - Ovarian Cancer - Product Status
Table 57: Diagnostic Test - Ovarian Cancer - Product Description
Table 58: BioFluidica Microtechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Circulating Tumor Cells Screening Assay - Ovarian Cancer - Product Status
Table 60: Circulating Tumor Cells Screening Assay - Ovarian Cancer - Product Description
Table 61: Bioindustry Park Silvano Fumero SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Diagnostic Kit - Ovarian Cancer - Product Status
Table 63: Diagnostic Kit - Ovarian Cancer - Product Description
Table 64: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 65: MBDAA Ovarian Cancer Test - Product Status
Table 66: MBDAA Ovarian Cancer Test - Product Description
Table 67: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 68: CELx Test - Ovarian Cancer - Product Status
Table 69: CELx Test - Ovarian Cancer - Product Description
Table 70: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Nanotrap Ovarian Cancer Biomarker Test - Product Status
Table 72: Nanotrap Ovarian Cancer Biomarker Test - Product Description
Table 73: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Diagnostic Test - Ovarian Cancer - Product Status
Table 75: Diagnostic Test - Ovarian Cancer - Product Description
Table 76: Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Ovatax - Product Status
Table 78: Ovatax - Product Description
Table 79: ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Prognostic Assay - Ovarian Cancer - Product Status
Table 81: Prognostic Assay - Ovarian Cancer - Product Description
Table 82: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Blood-Based Diagnostic Test - Ovarian Cancer - Product Status
Table 84: Blood-Based Diagnostic Test - Ovarian Cancer - Product Description
Table 85: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Ovarian Cancer Diagnostic Panel - Product Status
Table 87: Ovarian Cancer Diagnostic Panel - Product Description
Table 88: Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Biomarker Assay - Ovarian Carcinoma - Product Status
Table 90: Biomarker Assay - Ovarian Carcinoma - Product Description
Table 91: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: B7-H4 Assay - Product Status
Table 93: B7-H4 Assay - Product Description
Table 94: DcR3 (DD-C248) Assay - Product Status
Table 95: DcR3 (DD-C248) Assay - Product Description
Table 96: MIC-1 (DD-X065) Assay - Product Status
Table 97: MIC-1 (DD-X065) Assay - Product Description
Table 98: Spondin-2 (DD-P108) Assay - Product Status
Table 99: Spondin-2 (DD-P108) Assay - Product Description
Table 100: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Octava Test - Ovarian Cancer - Product Status
Table 102: Octava Test - Ovarian Cancer - Product Description
Table 103: Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 104: miRNA test - Ovarian Cancer - Product Status
Table 105: miRNA test - Ovarian Cancer - Product Description
Table 106: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 107: EXOTEST Ovarian - Product Status
Table 108: EXOTEST Ovarian - Product Description
Table 109: Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Diagnostic Test - Ovarian Cancer - Product Status
Table 111: Diagnostic Test - Ovarian Cancer - Product Description
Table 112: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 113: PTPL1 Based Prognostic Assay - Ovarian Cancer - Product Status
Table 114: PTPL1 Based Prognostic Assay - Ovarian Cancer - Product Description
Table 115: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 116: CA125 II Assay - Product Status
Table 117: CA125 II Assay - Product Description
Table 118: Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview
Table 119: IMAB027 Companion Diagnostic Test - Product Status
Table 120: IMAB027 Companion Diagnostic Test - Product Description
Table 121: GeneNews Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Biomarker Diagnostic Test - Ovarian Cancer - Product Status
Table 123: Biomarker Diagnostic Test - Ovarian Cancer - Product Description
Table 124: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Mass Spectrometry Based Ovarian Cancer Test - Product Status
Table 126: Mass Spectrometry Based Ovarian Cancer Test - Product Description
Table 127: GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Diagnostic Assay - Ovarian Cancer - Product Status
Table 129: Diagnostic Assay - Ovarian Cancer - Product Description
Table 130: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Diagnostic Assay - Ovarian Cancer - Product Status
Table 132: Diagnostic Assay - Ovarian Cancer - Product Description
Table 133: Hide and Seq Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Predictive Assay - Ovarian Cancer - Product Status
Table 135: Predictive Assay - Ovarian Cancer - Product Description
Table 136: Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 137: oncoFISH ovarian - Product Status
Table 138: oncoFISH ovarian - Product Description
Table 139: InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 140: OncoVue Ovarian - Product Status
Table 141: OncoVue Ovarian - Product Description
Table 142: IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Diagnostic Test - Ovarian Cancer - Product Status
Table 144: Diagnostic Test - Ovarian Cancer - Product Description
Table 145: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Biomarker Assay - Ovarian Cancer Chemoresistance - Product Status
Table 147: Biomarker Assay - Ovarian Cancer Chemoresistance - Product Description
Table 148: Methylation Based Biomarker Assay - Ovarian Cancer - Product Status
Table 149: Methylation Based Biomarker Assay - Ovarian Cancer - Product Description
Table 150: Multivariate Index Assay - Ovarian Cancer - Product Status
Table 151: Multivariate Index Assay - Ovarian Cancer - Product Description
Table 152: Protein Biomarker Diagnostic Assay - Ovarian Cancer Chemoresistance - Product Status
Table 153: Protein Biomarker Diagnostic Assay - Ovarian Cancer Chemoresistance - Product Description
Table 154: King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 155: Diagnostic Test - Ovarian Cancer - Product Status
Table 156: Diagnostic Test - Ovarian Cancer - Product Description
Table 157: KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 158: Ovarian Cancer Dx - Product Status
Table 159: Ovarian Cancer Dx - Product Description
Table 160: Lab Discoveries Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 161: Diagnostic Test - Ovarian Cancer - Product Status
Table 162: Diagnostic Test - Ovarian Cancer - Product Description

List of Figures
Figure 1: Ovarian Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Ovarian Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Ovarian Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Ovarian Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Ovarian Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 2X Oncology Inc
  • A&G Pharmaceutical Inc
  • Abnova Corp
  • Advanced Marker Discovery SL
  • Almac Diagnostics Ltd
  • ANGLE plc
  • AroCell AB
  • Aurelium BioPharma Inc.
  • Avant Diagnostics, Inc.
  • Axela Inc
  • Ayanda Biosystems SA
  • BARD1 Life Sciences Ltd
  • Becton Dickinson and Co
  • BioFluidica Microtechnologies LLC
  • Bioindustry Park Silvano Fumero SpA
  • Bioprognos SL
  • Celcuity LLC
  • Ceres Nanosciences Inc
  • Chronix Biomedical Inc
  • Clarient Inc
  • ClavGen Therapeutics LLC
  • Cleveland Diagnostics Inc.
  • Courtagen Life Sciences Inc
  • Dana-Farber Cancer Institute Inc
  • Diazyme Laboratories Inc
  • Eventus Diagnostics Inc
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • French National Institute of Health and Medical Research
  • Fujirebio Diagnostics Inc
  • Ganymed Pharmaceuticals AG
  • GeneNews Ltd
  • Georgia Institute of Technology
  • GlycoZym
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hide and Seq
  • Ikonisys Inc
  • InterGenetics Inc
  • IV Diagnostics Inc
  • John Hopkins University
  • King Abdullah University of Science and Technology
  • KIYATEC Inc
  • Lab Discoveries Ltd
  • Laboratorios SALVAT SA
  • Laboratory Corp of America Holdings
  • Lantern Pharma Inc
  • Louisville Bioscience, Inc.
  • MabCure Inc.
  • Massachusetts Institute of Technology
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Metabolon Inc
  • Milagen Inc
  • MyCartis NV
  • Myriad Genetics Inc
  • Nanocytomics LLC
  • National University of Singapore
  • NGeneBio Co Ltd
  • Novel Bio-spectrum Technologies Inc
  • Olympia Diagnostics, Inc
  • Oncgnostics GmbH
  • Oncimmune (USA) LLC
  • Orion Genomics LLC
  • Oryzon Genomics SA
  • OTraces Inc.
  • Peregrine Pharmaceuticals, Inc.
  • PeriRx LLC
  • Phenomenome Discoveries Inc
  • Precision Biologics Inc
  • Protagen AG
  • Proteomika
  • Provista Diagnostics Inc
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • SomaLogic Inc
  • Soricimed Biopharma Inc
  • Stage I Diagnostics Inc
  • SurExam Life Science & Technology Co.
  • Target Discovery Inc
  • Teva Pharmaceutical Industries Ltd
  • The University of Adelaide
  • Treos Bio Inc
  • University of Arkansas for Medical Sciences
  • University of California San Diego
  • University of Chicago
  • University of Montreal
  • University of Pittsburgh
  • University of South Florida
  • University of Texas MD Anderson Cancer Center
  • US Biomarkers Inc
  • Vermillion Inc
  • Vitatex Inc.
  • Vitruvian Biomedical Inc
  • Yale University
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll